Dark Forest Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Dark Forest Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-423,477	Closed	-$936K	–	1400
2025 Q1	$936K	Buy	+423,477	New	+$1.67M	0.04%	723
2024 Q1	–	Sell	-13,463	Closed	-$88.2K	–	752
2023 Q4	$88.2K	Buy	+13,463	New	+$87K	0.01%	413
2022 Q4	–	Sell	-30	Closed	-$1K	–	1365
2022 Q3	$1K	Sell	30 -347	-92%	-$8.71K	﹤0.01%	1060
2022 Q2	$11K	Sell	377 -51	-12%	-$1.62K	﹤0.01%	517
2022 Q1	$15K	Buy	428 +424	+10,600%	+$14.2K	﹤0.01%	879
2021 Q4	$0	Buy	+4	New	+$162	﹤0.01%	1661
2021 Q3	–	Sell	-87	Closed	-$4K	–	1444
2021 Q2	$4K	Buy	+87	New	+$3.37K	﹤0.01%	712

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Dark Forest Capital Management's MRVI Position: Q2 2025 in Review

Dark Forest Capital Management sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 423,477 shares — an estimated $936K sold.

Dark Forest Capital Management first reported a position in MRVI in Q2 2021 and held it in 7 quarters. The position peaked at $936K in Q1 2025. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

Dark Forest Capital Management reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
Dark Forest Capital Management sold 423,477 Maravai LifeSciences shares in Q2 2025, an estimated $936K.
Dark Forest Capital Management first reported a position in Maravai LifeSciences in Q2 2021 and held it in 7 quarters.
Dark Forest Capital Management's Maravai LifeSciences position peaked at $936K in Q1 2025.
150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.